JJ
Johnson John
首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Johnson John, 首席执行官. Insider active across 6 companies, notably Strongbridge Biopharma plc. In total, 22 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €1.9m. History available since 2 July 2021. The latest transaction was disclosed on 19 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Johnson John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
14,150 股Common StockSEC:0001410781-26-000006:0
135,400 股@ US$7.215843.9% 占其流量Common StockSEC:0001410781-25-000006:0
11,802 股@ US$31.2689.3% 占其流量Common StockSEC:0001410781-25-000004:0
107,500 股@ US$7.315963.0% 占其流量Common StockSEC:0001867096-25-000141:0
4,073 股@ US$10.61100.0% 占其流量Common StockSEC:0000805928-25-000081:0
50,000 股0Common StockSEC:0001867096-25-000108:0
8,333 股0Common StockSEC:0001104659-25-053093:0
500,000 股0Common StockSEC:0000950170-24-139240:0
11,904 股0Common StockSEC:0000805928-24-000121:0
8,333 股0Common StockSEC:0001104659-24-073599:0
10,653 股Common StockSEC:0000805928-24-000099:0
50,000 股0Common StockSEC:0001867096-24-000106:0
89,571 股Common StockSEC:0001867096-24-000039:0
215,600 股@ US$1.99100.0% 占其流量Common StockSEC:0001867096-24-000036:0
42,500 股0Common StockSEC:0001867096-23-000099:0
6,459 股0Common StockSEC:0000805928-23-000066:0
15,000 股0Common StockSEC:0001867096-22-000090:0
478,312 股Common StockSEC:0000899243-21-039749:0
610,092 股Ordinary SharesSEC:0001179110-21-009282:0
334,868 股@ US$2.0681.8% 占其流量Ordinary SharesSEC:0001179110-21-009224:0
478,312 股Common StockSEC:0000899243-21-039341:0
50,867 股@ US$3.0818.2% 占其流量Ordinary SharesSEC:0001179110-21-007439:0
About Johnson John
JOHNSON JOHN is Directeur Général. He has been linked to 22 filings in total, and across the 22 sampled filings between 2021-07-07 and 2026-06-23, sales total 1859438 EUR and buys total 0 EUR. His listed companies are Xeris Biopharma Holdings, Inc., Axogen, Inc., Strongbridge Biopharma plc, Verastem, Inc. and Applied Therapeutics, Inc.